
|Articles|December 1, 2004
Transaction is a surprise, but makes sense, analysts say
Although the news of Advanced Medical Optics Inc. (AMO) buying VISX caught many on Wall Street off guard, several analysts are saying the deal makes sense in retrospect.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
Ocular pickleball injuries rise sharply with increasing game popularity
3
AAO 2025: The evolution of eye care on display at AAO 2025
4
AAO 2025: Which lens to consider in patients with pseudoexfoliation
5